Since its inception in 1975, ICRF has raised over $98 million USD to support groundbreaking Israeli cancer research and funded over 2,885 cancer research grants. The results of these research projects have a significant impact in Montreal, across Canada and throughout the world.
Today, ICRF is the largest nongovernmental source of cancer research funding in Israel. ICRF-funded scientists have been instrumental in the development of breakthrough FDA-approved drugs Gleevec©, Doxil© and Velcade© and include the first two Israeli Nobel Prize Laureates in Chemistry. ICRF grantees continue to make major cancer research breakthroughs and are at the forefront of discoveries in nano-medicine, immunotherapy, stem cell research and targeted therapies.
Shared 1 month ago
218 views
Shared 5 months ago
342 views
Shared 9 months ago
83 views
Shared 10 months ago
135 views
Shared 1 year ago
22 views
Shared 1 year ago
406 views
Shared 1 year ago
68 views
Shared 2 years ago
108 views
Shared 6 years ago
718 views
